Molecular laboratory in human papillomavirus (HPV) and cancer

Laura Joanna Tapia-Vela; Germán Campuzano-Zuluaga

2021, Number 2

Next >>

Medicina & Laboratorio 2021; 25 (2)

Molecular laboratory in human papillomavirus (HPV) and cancer

Tapia-Vela LJ, Campuzano-Zuluaga G

Full text

How to cite this article

Language: Spanish
References: 17
Page: 463-465
PDF size: 40.42 Kb.

Text Extraction

No abstract.

REFERENCES

Leal SM, Jr., Gulley ML. Current and emerging molecular tests for human papillomavirus-related neoplasia inthe genomic era. J Mol Diagn 2017;19:366-377. https://doi.org/10.1016/j.jmoldx.2017.01.006.
Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. 1941. ArchPathol Lab Med 1997;121:211-224.
National Cancer Institute (NCI). The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses.National Cancer Institute Workshop. Jama 1989;262:931-934.
Gibb RK, Martens MG. The impact of liquid-based cytology in decreasing the incidence of cervical cancer. RevObstet Gynecol 2011;4:S2-11.
Salazar KL, Duhon DJ, Olsen R, Thrall M. A review of the FDA-approved molecular testing platforms for humanpapillomavirus. J Am Soc Cytopathol 2019;8:284-292. https://doi.org/10.1016/j.jasc.2019.06.001.
Nayar R, Goulart RA, Davey DD. Primary HPV cervical cancer screening in the United States: Are we ready? JAm Soc Cytopathol 2018;7:50-55. https://doi.org/10.1016/j.jasc.2017.12.001.
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of thehuman genome. Nature 2001;409:860-921. https://doi.org/10.1038/35057062.
Allison DB, Maleki Z. HPV-related head and neck squamous cell carcinoma: An update and review. J Am SocCytopathol 2016;5:203-215. https://doi.org/10.1016/j.jasc.2015.12.001.
de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site,country and HPV type. Int J Cancer 2017;141:664-670. https://doi.org/10.1002/ijc.30716.
de Oliveira TH, do Amaral CM, de França-São Marcos B, Nascimento KCG, de Miranda-Rios AC, QuixabeiraDCA, et al. Presence and activity of HPV in primary lung cancer. J Cancer Res Clin Oncol 2018;144:2367-2376. https://doi.org/10.1007/s00432-018-2748-8.
de Souza CR, Almeida MC, Khayat AS, da Silva EL, Soares PC, Chaves LC, et al. Association between Helicobacterpylori, Epstein-Barr virus, human papillomavirus and gastric adenocarcinomas. World J Gastroenterol2018;24:4928-4938. https://doi.org/10.3748/wjg.v24.i43.4928.
Türkay D, Vural Ç, Sayan M, Gürbüz Y. Detection of human papillomavirus in esophageal and gastroesophagealjunction tumors: A retrospective study by real-time polymerase chain reaction in an instutional experience fromTurkey and review of literature. Pathol Res Pract 2016;212:77-82. https://doi.org/10.1016/j.prp.2015.10.007.
El-Sheikh N, Mousa NO, Tawfeik AM, Saleh AM, Elshikh I, Deyab M, et al. Assessment of human papillomavirusinfection and risk factors in Egyptian women with breast cancer. Breast Cancer 2021;15:1178223421996279.https://doi.org/10.1177/1178223421996279.
Islam MS, Chakraborty B, Panda CK. Human papilloma virus (HPV) profiles in breast cancer: future management.Ann Transl Med 2020;8:650-650. https://doi.org/10.21037/atm-19-2756.
Ministerio de Salud y Protección Social, Instituto Nacional de Cancerología-ESE. Guía de Práctica Clínicapara la detección y manejo de lesiones precancerosas de cuello uterino. Guía No. 44. Bogotá D.C.: Ministerio deSalud y Protección Social; 2014. Acceso Acceso 28 de marzo de 2021. Disponible en https://www.cancer.gov.co/Gu%C3%ADas-y-Protocolos/Gu%C3%ADas-de-Practica-clinica/LPC-Guia-profesionales.pdf.
Toro-Montoya AI, Tapia-Vela LJ. Virus del papiloma humano (VPH) y cáncer. Med Lab 2021;25:467-483.https://doi.org/10.36384/01232576.431.
Mesa-Arango JA, Tapia-Vela LJ, Loaiza-Díaz N, Echeverry-Chica J, Toro-Montoya AI. Detección y genotipificacióndel virus del papiloma humano de alto riesgo mediante PCR multiplex en tiempo real (RT-PCR VPH AR).Med Lab 2021;25:547-550. https://doi.org/10.36384/01232576.439.